tiprankstipranks
Rallybio (RLYB)
NASDAQ:RLYB
US Market
Holding RLYB?
Track your performance easily

Rallybio (RLYB) Income Statement

286 Followers

Rallybio Income Statement

Last quarter (Q3 2024), Rallybio's total revenue was $299.00K, an increase of Infinity% from the same quarter last year. In Q3, Rallybio's net income was $-11.47M. See Rallybio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 598.00K---$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 598.00K-----
Operating Expense
$ 70.60M$ 78.93M$ 67.88M$ 45.65M$ 25.30M$ 17.64M
Operating Income
$ -70.00M$ -78.93M$ -67.88M$ -45.65M$ -25.30M$ -17.64M
Net Non Operating Interest Income Expense
$ 4.85M$ 6.15M$ 1.96M$ 44.00K$ 122.00K$ 158.00K
Other Income Expense
$ 1.45M$ -1.78M$ -733.00K$ 1.41M$ 241.00K$ 24.00K
Pretax Income
$ -65.72M$ -74.56M$ -66.65M$ -45.51M$ -24.94M$ -17.46M
Tax Provision
----$ -15.00K$ 0.00
Earnings From Equity Interest Net Of Tax
$ -2.42M$ -2.04M$ -1.07M$ -1.50M$ -1.52M$ -103.00K
Net Income Common Stockholders
$ -66.97M$ -74.56M$ -66.65M$ -47.01M$ -26.45M$ -17.56M
Basic EPS
$ -1.60$ -1.84$ -2.09$ -1.84$ -1.52$ -1.01
Diluted EPS
$ -1.60$ -1.84$ -2.09$ -1.84$ -1.52$ -1.01
Basic Average Shares
$ 170.14M$ 40.45M$ 31.82M$ 25.52M$ 17.39M$ 17.39M
Diluted Average Shares
$ 170.14M$ 40.45M$ 31.82M-$ 17.39M$ 17.39M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 70.60M$ 78.93M$ 67.88M$ 45.65M$ 25.30M$ 17.64M
Net Income From Continuing And Discontinued Operation
$ -66.97M$ -74.56M$ -66.65M$ -47.01M$ -26.45M$ -17.56M
Normalized Income
$ -32.60M$ -59.54M-$ -37.95M$ -26.45M$ -17.56M
Interest Expense
----$ 49.00K$ 39.00K
EBIT
$ -70.00M$ -78.93M$ -67.88M$ -45.50M$ -24.89M$ -17.42M
EBITDA
$ -70.20M$ -78.78M$ -67.72M$ -45.39M$ -24.83M$ -17.39M
Currency in USD

Rallybio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis